257 related articles for article (PubMed ID: 2951008)
1. The fibrinolytic system and its pharmacologic activation for thrombolysis.
Sherry S
Cardiol Clin; 1987 Feb; 5(1):1-11. PubMed ID: 2951008
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological potentials for activating the fibrinolytic system].
Markwardt F
Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
[TBL] [Abstract][Full Text] [Related]
3. [Current situation and developmental trends in the field of thrombolytic agents].
Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):5-8. PubMed ID: 4134480
[No Abstract] [Full Text] [Related]
4. Concepts of clot lysis.
Francis CW; Marder VJ
Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
[TBL] [Abstract][Full Text] [Related]
5. [Position and developmental trends in fibrinolytic therapy].
Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):6-17. PubMed ID: 2427416
[TBL] [Abstract][Full Text] [Related]
6. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
Marder VJ; Francis CW
Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
[No Abstract] [Full Text] [Related]
7. [Thrombolytics and their use].
Alessi MC; Juhan-Vague I
Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
[TBL] [Abstract][Full Text] [Related]
8. [The fibrinolytic system and its activators].
Seifried E
Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
[TBL] [Abstract][Full Text] [Related]
9. Importance of fibrin specificity in therapeutic thrombolysis and the rationale of using sequential and synergistic combinations of tissue plasminogen activator and pro-urokinase.
Gurewich V
Semin Thromb Hemost; 1989 Apr; 15(2):123-8. PubMed ID: 2501871
[No Abstract] [Full Text] [Related]
10. [Tissue plasminogen activator: mechanism of action and thrombolytic properties].
Páramo JA; Collen D
Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389
[No Abstract] [Full Text] [Related]
11. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
Collen D; Lijnen HR
Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
[TBL] [Abstract][Full Text] [Related]
12. [Long-lasting activation of the fibrinolytic system in blood and its clinical application].
Bielawiec M
Pol Tyg Lek; 1969 Jan; 24(2):63-6. PubMed ID: 4240415
[No Abstract] [Full Text] [Related]
13. [Actual state of thrombolytic treatment of recent vein thrombosis and pulmonary embolism (author's transl)].
Verstraete M
J Mal Vasc; 1981; 6(4):251-6. PubMed ID: 7198677
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolysis--a review.
Kane KK
Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic agents.
Sherry S
Dis Mon; 1969 May; ():3-32. PubMed ID: 4241828
[No Abstract] [Full Text] [Related]
16. [Streptokinase in arterial diseases].
Baracchi G
Minerva Med; 1979 Jan; 70(2):143-7. PubMed ID: 155227
[No Abstract] [Full Text] [Related]
17. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
18. Experimental thrombolysis by perfusion. II. Comparative study on the effect of streptokinase, urokinase and plasmin.
Egeblad K; Bertelsen S
Acta Chir Scand; 1969; 135(6):486-90. PubMed ID: 4244115
[No Abstract] [Full Text] [Related]
19. Plasminogen activators: a comparison.
Baruah DB; Dash RN; Chaudhari MR; Kadam SS
Vascul Pharmacol; 2006 Jan; 44(1):1-9. PubMed ID: 16275118
[TBL] [Abstract][Full Text] [Related]
20. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity].
Fischer M
Thromb Diath Haemorrh; 1970 Jun; 23(3):513-52. PubMed ID: 4247030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
